Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia, resulting from defects in insulin secretion, insulin resistance, or both (
1). Symptoms of hyperglycemia may include frequent urination, weight loss, excessive thirst, increased appetite, susceptibility to infections, ketoacidosis, and long-term complications such as retinopathy, nephropathy, and peripheral neuropathy (
2). There are four types of DM. In type 1 DM, the immune system produces antibodies like Anti-GAD, ICA, and IA-2 against pancreatic β-cells, necessitating lifelong insulin therapy. Type 2 DM is characterized by insulin resistance, often seen in obese adults, which can lead to β-cell failure. Gestational DM can develop in some pregnant women due to steroid hormone production from the placenta. Special types of DM can present in a monogenic form, causing β-cell dysfunction and resulting in hyperglycemia, as seen in conditions like maturity-onset diabetes of the young (MODY) (
3,
4).
In type 2 diabetes, insulin resistance occurs in muscle tissue and adipocytes. Decreased β-cell function and increased glucagon secretion are common phenomena. These patients also experience increased hepatic glucose production. Insulin binds to the β2α2 receptor in muscle, adipocytes, and liver, affecting cells via a tyrosine kinase mechanism mediated by PI3-K and PKB/Akt to facilitate glucose entry through GLUT-4 (
5,
6). Insulin resistance may arise from abnormalities in insulin receptor autophosphorylation activity, elevated tyrosine phosphatase activity of PTP1β leading to insulin receptor inactivation, or phosphatase action dephosphorylating IRS-1 within the insulin signaling pathway (
7).
Osteoporosis, a complication of diabetes, is characterized by decreased bone mass. Disruption in bone resorption and formation turnover leads to decreased bone density. Individuals with DM have a higher risk of developing osteoporosis, and bone tissue repair is often delayed following fractures (
8,
9). During exercise, mechanical stress on the bone induces fluid flow in the lacunar-canalicular network, leading to intracellular responses such as increased intracellular calcium, matrix production, and osteogenesis (
10,
11). Regular weight-bearing and muscle-strengthening exercises can help prevent osteoporosis. Walking enhances blood sugar regulation, boosts bone density through weight loss, and mitigates detrimental impacts on bones (
12).
Inflammation can disrupt metabolic functions, but physical activity can increase anti-inflammatory cytokines like adiponectin, IL-4, and IL-10 while reducing pro-inflammatory cytokines such as leptin, RBP4, CRP, and TNFα. This can improve insulin sensitivity, reduce inflammation, better manage diabetes, increase bone density, control weight, and enhance bone health markers affected by inflammation (
13,
14). Recently, sports medicine experts have employed innovative interventions like high-intensity interval training (HIIT) instead of continuous endurance training (CET) to manage metabolic conditions like osteoporosis and obesity. Studies suggest that HIIT may offer superior benefits in improving bone density compared to CET. This research examines how HIIT impacts osteocalcin, alkaline phosphatase, and C-telopeptide (CTX) levels, crucial factors in mitigating bone tissue degradation in diabetic individuals. In diabetic patients, markers of bone formation decrease while those of bone resorption increase, indicating a potential link between diabetes and bone fragility (
15).
Bone alkaline phosphatase is a crucial marker for bone formation and is an isoenzyme distinguishable from others due to its degradation at 56°C. Osteoblasts are a significant source of alkaline phosphatase, and serum levels of this enzyme indicate osteoblastic activity (
16). Osteocalcin, rich in gamma-carboxy glutamic acid, is vitamin K-dependent and a prevalent non-collagenous protein in bone, contributing to bone mineralization. Osteocalcin levels are regulated by calcitonin, parathyroid hormone, and vitamin D3 (
17). It is a bone formation marker, demonstrating osteoblast activity in bone metabolism, and is also involved in glucose metabolism (
17,
18).
C-telopeptide is a breakdown product from the carboxy-terminal region of collagen type I, serving as a specific serum marker for assessing bone turnover. Increased CTX levels in serum and urine indicate bone resorption (
19). Irisin, a polypeptide hormone secreted from the muscle transmembrane protein FNDC5 during physical activity, increases bone formation and decreases bone resorption, promoting bone health. Irisin also facilitates the transformation of white fat into brown fat, reducing obesity, diabetes, and other health problems (
20,
21).
Diabetes can impact bone health through mechanisms such as obesity, altered insulin levels, increased urinary excretion leading to reduced intestinal calcium absorption, disrupted parathyroid hormone and vitamin D homeostasis, impaired kidney function, and reduced insulin-like growth factor-i levels. In type 2 diabetes (T2DM), bone microstructure is compromised as osteoblast apoptosis increases, osteoblast differentiation decreases, and osteoclast-mediated bone resorption rises (
22,
23). Exercise enhances glucose uptake into muscle cells via GLUT-4, boosts insulin receptor substrates (IRS), and promotes muscle growth. Over 75% of glucose uptake is attributed to insulin stimulation in muscle tissue, increasing tissue sensitivity to insulin (
24).
Some studies suggest that HIIT has a more significant impact on metabolic function compared to CET, while others indicate no discernible difference between the two methods (
25,
26). The HIIT can burn approximately 200-250 kcal in individuals (
27). Bone consists of protein and minerals and contains two cell types: Osteoclasts, responsible for bone resorption, and osteoblasts, which aid in bone formation. As individuals age, osteoclast activity tends to increase, leading to decreased bone mass (
28). Regular physical activity effectively manages metabolic conditions such as type 2 diabetes and obesity. Diabetic individuals are typically advised to engage in 30 minutes of low to moderate-intensity aerobic exercise (
29).